DK1273296T3 - Kombination af acetyldinalin og docetaxel - Google Patents

Kombination af acetyldinalin og docetaxel

Info

Publication number
DK1273296T3
DK1273296T3 DK02254337T DK02254337T DK1273296T3 DK 1273296 T3 DK1273296 T3 DK 1273296T3 DK 02254337 T DK02254337 T DK 02254337T DK 02254337 T DK02254337 T DK 02254337T DK 1273296 T3 DK1273296 T3 DK 1273296T3
Authority
DK
Denmark
Prior art keywords
docetaxel
combination
acetyldinalin
acetyldinaline
synergistic
Prior art date
Application number
DK02254337T
Other languages
Danish (da)
English (en)
Inventor
William Richard Grove
Ronald Lynn Merriman
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Application granted granted Critical
Publication of DK1273296T3 publication Critical patent/DK1273296T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Seasonings (AREA)
  • Medicinal Preparation (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Insulated Conductors (AREA)
DK02254337T 2001-07-02 2002-07-01 Kombination af acetyldinalin og docetaxel DK1273296T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30241501P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
DK1273296T3 true DK1273296T3 (da) 2004-03-01

Family

ID=23167645

Family Applications (1)

Application Number Title Priority Date Filing Date
DK02254337T DK1273296T3 (da) 2001-07-02 2002-07-01 Kombination af acetyldinalin og docetaxel

Country Status (20)

Country Link
US (1) US20030083366A1 (cs)
EP (1) EP1273296B1 (cs)
JP (1) JP2003055208A (cs)
KR (1) KR20030015829A (cs)
CN (1) CN1394601A (cs)
AT (1) ATE254915T1 (cs)
AU (1) AU5063302A (cs)
CA (1) CA2391753A1 (cs)
CZ (1) CZ20022216A3 (cs)
DE (1) DE60200101T2 (cs)
DK (1) DK1273296T3 (cs)
ES (1) ES2208626T3 (cs)
HK (1) HK1049794A1 (cs)
HU (1) HUP0202120A3 (cs)
IL (1) IL150396A0 (cs)
PL (1) PL354825A1 (cs)
PT (1) PT1273296E (cs)
SK (1) SK9342002A3 (cs)
TR (1) TR200302193T4 (cs)
ZA (1) ZA200205216B (cs)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20050206A1 (es) * 2003-05-26 2005-03-26 Schering Ag Composicion farmaceutica que contiene un inhibidor de histona deacetilasa
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
EP2404596A1 (en) * 2006-03-23 2012-01-11 TMRC Co., Ltd. Kit for Cancer Treatment and Pharmaceutical Composition for Cancer Treatment
EP2178531A4 (en) * 2007-07-02 2012-01-11 Yu Ming METHODS AND COMPOSITIONS, TARGETS FOR COMBINED CANCER TREATMENTS
WO2012003413A1 (en) * 2010-06-30 2012-01-05 The Broad Institute, Inc. Novel solid forms of tacedinaline
US8691875B2 (en) 2011-07-01 2014-04-08 Broad Institute, Inc. Solid forms of tacedinaline

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ219974A (en) * 1986-04-22 1989-08-29 Goedecke Ag N-(2'-aminophenyl)-benzamide derivatives, process for their preparation and their use in the control of neoplastic diseases
WO1998047500A1 (en) * 1997-04-24 1998-10-29 Warner-Lambert Company Use of acetyldinaline for the manufacture of a medicament for the treatment of renal cell carcinoma
EE200100187A (et) * 1998-09-25 2002-08-15 Warner-Lambert Company Vähi kemoteraapia atsetüüldinaliiniga kombinatsioonis gemtsitabiini, kapetsitabiini või tsisplatiiniga
AP2001002175A0 (en) * 1998-12-22 2001-06-21 Warner Lambert Co Combination chemotherapy.
GB9904386D0 (en) * 1999-02-25 1999-04-21 Pharmacia & Upjohn Spa Antitumour synergistic composition
HUP0203153A3 (en) * 1999-11-10 2005-01-28 Warner Lambert Co Combination chemotherapy

Also Published As

Publication number Publication date
ATE254915T1 (de) 2003-12-15
HUP0202120A2 (hu) 2003-01-28
AU5063302A (en) 2003-01-09
ZA200205216B (en) 2004-02-10
IL150396A0 (en) 2002-12-01
TR200302193T4 (tr) 2004-02-23
PL354825A1 (en) 2003-01-13
SK9342002A3 (en) 2003-07-01
EP1273296A3 (en) 2003-01-22
ES2208626T3 (es) 2004-06-16
CN1394601A (zh) 2003-02-05
PT1273296E (pt) 2004-03-31
HU0202120D0 (cs) 2002-09-28
CA2391753A1 (en) 2003-01-02
DE60200101D1 (de) 2004-01-08
JP2003055208A (ja) 2003-02-26
EP1273296A2 (en) 2003-01-08
HK1049794A1 (zh) 2003-05-30
DE60200101T2 (de) 2004-08-26
KR20030015829A (ko) 2003-02-25
CZ20022216A3 (cs) 2003-05-14
US20030083366A1 (en) 2003-05-01
HUP0202120A3 (en) 2005-01-28
EP1273296B1 (en) 2003-11-26

Similar Documents

Publication Publication Date Title
DK0912535T3 (da) Konjugater af cis-docosahexaensyre og paclitaxel
DK0914116T3 (da) Kompositstoffer omfattende konjugater af cis-docosahexaensyre og Taxotere
DK1503788T3 (da) Behandling af alpha-galactosidase A-deficiens
SG148864A1 (en) Methods of treating cancer and related methods
NO20024610L (no) Synergistiske metoder og blandinger for behandling av kreft
DK1372650T3 (da) Kombinationer indeholdende et antidiarrémiddel og en epothilon eller et epothilonderivat
NO20054988D0 (no) Preparater og metoder for behandling av cancer
CY1105892T1 (el) Θepαπεια του ξανθωματος με παραγωγα αζετιδινονης ως αναστολεις απορροφησης στepολης
TW200501960A (en) Synergistic kits and compositions for treating cancer
CY1109741T1 (el) Sns-595 και μεθοδοι χρησης αυτου
DE59908889D1 (de) Gemeinsame Quellen- und Kanalcodierung
NO20041214L (no) Substituerte benzimidazolforbindelser og deres anvendelse for behandling av cancer
IL161501A0 (en) Methods of preventing and treating flavivirus infection in animals
DK1273296T3 (da) Kombination af acetyldinalin og docetaxel
DE50210782D1 (de) Tor und führungsschienenanordnung
EE200200574A (et) Fulvestrandi kasutamine resistentse rinnavähi ravis
UY26431A1 (es) Quimioterapia de combinación
NO20053903D0 (no) Nukleotidlipidesterderivater.
ATE469167T1 (de) Anti-infarkt-moleküle
DK1372652T3 (da) Kombination af docetaxel og flavopiridol
DK1379242T3 (da) Fremgangsmåde til behandling af cancer og sammensætninger til anvendelse derved
FI20000549A0 (fi) Sexi-hoito ja hierontapöytä
ZA200103745B (en) Therapeutic light source and method.
ZA200103743B (en) Therapeutic light source and method.
NO20011900L (no) Brönnbehandlingsfluider og fremgangsmåter for anvendelse derav